Viagra for blue babies likely to be trialledBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7358.238/h (Published 03 August 2002) Cite this as: BMJ 2002;325:238
- Owen Dyer
The efficacy and safety of sildenafil (Viagra) as a treatment for pulmonary hypertension is likely to be tested in at least one controlled trial, after controversy was stirred by reports that the drug is being given to newborns with “blue baby” syndrome (27 July,181).
The drug has been used on babies at the Royal Brompton Children's Hospital in London and several other centres around the world. The science magazine New Scientist reported that children as young as 8 hours old have also been given the drug …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial